IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00516672Phase I Study of Pazopanib Alone and In Combination With Lapatinib in Japanese Patients With Solid Tumors.
NCT00158782Study Of Safety And Tolerability Of GW786034 Given With Lapatinib In Cancer Patients
NCT00258050To Examine The Effects Of Lapatinib On Orally And Intravenously Administered Midazolam In Cancer Patients